Harrow Health (HROWL) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 0 251 sessions, October 10, 2024 to October 10, 2025
- Largest daily move
- -1.9% close of July 15, 2025
- 1-year change
- +0% closing prices, October 10, 2024 to October 10, 2025
Company Description
HROWL has gained 0.0% over the past year. The last closing price was $25.61.
For FY2025, Harrow Health reported revenue of $272.3M with net income of -$5.1M and diluted earnings per share of -$0.14. The company operates at a net profit margin of -1.9%.
This page collects what Stock Titan holds for HROWL, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Harrow Health (HROWL) closed at $25.61 on October 10, 2025. Over the past 12 months, the price has gained 0.0%.
HROWL Metrics & Rankings
Price returns through October 10, 2025. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
SEC Filings
Harrow Health has filed 5 recent SEC filings, including 4 Form 4, 1 Form 8-K. The most recent filing was submitted on June 3, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all HROWL SEC filings →
Financial Highlights
Harrow Health generated $272.3M in revenue in FY2025, retaining a 75.0% gross margin, operating income reached $30.5M (11.2% operating margin), and net income was -$5.1M, reflecting a -1.9% net profit margin. Diluted earnings per share stood at -$0.14. The company generated $43.9M in operating cash flow. With a current ratio of 2.20, the balance sheet reflects a strong liquidity position.